Assessing blood glucose control in women with gestational diabetes can be challenging. The standard of care remains visual inspection of blood glucose paper diaries of self-performed capillary monitoring during regular meeting in High Risk pregnancy clinics. The researchers are interested in preforming a randomized control trial comparing women with the diagnosis of gestational diabetes with regular High-Risk clinic surveillance to digital monitoring using an application in a Smart-phone and submitting those values via email in addition to the regular clinic appointments. The Primary outcome of the trial is to assess the compliance of the research group as compared to the control group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
SINGLE
Enrollment
100
Wolfson medical center
Holon, Israel
RECRUITINGAssessing the compliance of the research group compared to the control group.
By calculating the amount of daily glucose measurements in the research group compared to the number of glucose measurements in the control group
Time frame: 18 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.